Maker of cancer test hopes to replace mammography.Matritech, Inc. in Newton, MA, has announced that it has completed its "proof of clinical concept" investigations on a new test to detect breast cancer. The test uses the company's proprietary NMP NMP New Millennium Program (NASA) NMP National Military Park (National Park Service) NMP N-Methylpyrrolidone NMP Network Management Protocol NMP Not My Problem 66 blood screen, which correlates levels of nuclear matrix protein (NMP) in body fluids with the presence of cancer. A similar test for bladder cancer bladder cancer Malignant tumour of the bladder. The most significant risk factor associated with bladder cancer is smoking. Exposure to chemicals called arylamines, which are used in the leather, rubber, printing, and textiles industries, is another risk factor. has already gained FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval in the US. The company hopes the new breast cancer test will be more accurate and comfortable for patients than mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her . |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion